000 01640 a2200445 4500
005 20250513123325.0
264 0 _c19971021
008 199710s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/s002280050289
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSnyman, J R
245 0 0 _aEffects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1997
300 _a277-80 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aBlood Proteins
_xmetabolism
650 0 4 _aCalcitriol
_xadministration & dosage
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aEosinophil Granule Proteins
650 0 4 _aEosinophils
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunoglobulin E
_xmetabolism
650 0 4 _aImmunoglobulin G
_xmetabolism
650 0 4 _aLeukocyte Count
650 0 4 _aLymphocyte Count
650 0 4 _aMale
650 0 4 _aParasite Egg Count
650 0 4 _aPraziquantel
_xtherapeutic use
650 0 4 _aRibonucleases
650 0 4 _aSchistosomiasis haematobia
_xblood
650 0 4 _aSchistosomicides
_xadministration & dosage
650 0 4 _aSingle-Blind Method
700 1 _ade Sommers, K
700 1 _aSteinmann, M A
700 1 _aLizamore, D J
773 0 _tEuropean journal of clinical pharmacology
_gvol. 52
_gno. 4
_gp. 277-80
856 4 0 _uhttps://doi.org/10.1007/s002280050289
_zAvailable from publisher's website
999 _c9228672
_d9228672